ZA762920B - Novel pharmaceutical preparation adapted for oral administration - Google Patents

Novel pharmaceutical preparation adapted for oral administration

Info

Publication number
ZA762920B
ZA762920B ZA762920A ZA762920A ZA762920B ZA 762920 B ZA762920 B ZA 762920B ZA 762920 A ZA762920 A ZA 762920A ZA 762920 A ZA762920 A ZA 762920A ZA 762920 B ZA762920 B ZA 762920B
Authority
ZA
South Africa
Prior art keywords
oral administration
pharmaceutical preparation
novel pharmaceutical
preparation adapted
novel
Prior art date
Application number
ZA762920A
Other languages
English (en)
Inventor
Vies J Van Der
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA762920B publication Critical patent/ZA762920B/xx
Priority to DK211377A priority Critical patent/DK211377A/da
Priority to AR267612A priority patent/AR212996A1/es
Priority to ES458836A priority patent/ES458836A1/es
Priority to NL7705368A priority patent/NL7705368A/xx
Priority to SE7705687A priority patent/SE425789B/xx
Priority to FI771549A priority patent/FI57762C/fi
Priority to CH616477A priority patent/CH630645A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA762920A 1975-05-30 1976-05-17 Novel pharmaceutical preparation adapted for oral administration ZA762920B (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DK211377A DK211377A (da) 1976-05-17 1977-05-13 17beta-estere af ostradiol
AR267612A AR212996A1 (es) 1976-05-17 1977-05-13 Procedimiento para preparar 17b-esteres de estradiol
ES458836A ES458836A1 (es) 1976-05-17 1977-05-14 Procedimiento para preparar nuevos 17 beta-esteres de estra-diol.
NL7705368A NL7705368A (nl) 1976-05-17 1977-05-16 Werkwijze voor het bereiden van nieuwe 17(beta)-esters van oestradiol.
SE7705687A SE425789B (sv) 1976-05-17 1977-05-16 Forfarande for framstellning av nya 17beta-estrar av ostradiol
FI771549A FI57762C (fi) 1976-05-17 1977-05-16 Foerfarande foer framstaellning av nya estradiol-17beta-estrar
CH616477A CH630645A5 (en) 1976-05-17 1977-05-17 Process for preparing novel 17beta esters of oestradiol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7506407A NL7506407A (nl) 1975-05-30 1975-05-30 Werkwijze ter bereiding van een oraal werkzaam far- maceutisch preparaat.

Publications (1)

Publication Number Publication Date
ZA762920B true ZA762920B (en) 1977-04-27

Family

ID=19823842

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA762920A ZA762920B (en) 1975-05-30 1976-05-17 Novel pharmaceutical preparation adapted for oral administration

Country Status (16)

Country Link
US (1) US4071623A (pt)
JP (2) JPS51144736A (pt)
AU (1) AU505898B2 (pt)
BE (1) BE842329A (pt)
DE (2) DE2661011C2 (pt)
FR (1) FR2312256A1 (pt)
GB (2) GB1553731A (pt)
GR (1) GR58257B (pt)
HU (1) HU176742B (pt)
IE (1) IE42692B1 (pt)
IL (1) IL49640A (pt)
LU (1) LU75039A1 (pt)
NL (1) NL7506407A (pt)
NZ (1) NZ180980A (pt)
PH (1) PH13841A (pt)
ZA (1) ZA762920B (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7613248A (nl) * 1976-11-26 1978-05-30 Akzo Nv Werkwijze voor het bereiden van nieuwe steroid- esters.
DD148185A1 (de) * 1979-05-21 1981-05-13 Claus Claussen Verfahren zur herstellung einer oral applizierbaren arzneiform
US4315925A (en) * 1980-05-30 1982-02-16 University Of Kentucky Research Foundation Method of administering natural female sex hormones
US4816257A (en) * 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
US4863911A (en) * 1986-08-04 1989-09-05 University Of Florida Method for treating male sexual dysfunction
DE59002150D1 (de) * 1989-04-18 1993-09-09 Henning Berlin Gmbh Orale zubereitungsform des oestradiolvalerats.
DK0461290T3 (da) 1990-06-14 1994-02-21 Henning Berlin Gmbh Væskefyldte stikkapsler
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
CA2159419C (en) * 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
DE19619045C1 (de) * 1996-05-02 1997-11-13 Jenapharm Gmbh Verwendung von Kombinationspräparaten zur Behandlung hypogonadaler Männer sowie Männern mit Hypophysenerkrankungen
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6660726B2 (en) * 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
CA2415349A1 (en) * 2000-08-23 2002-02-28 Akzo Nobel N.V. Testosterone ester formulation for human use
US20020107230A1 (en) * 2000-12-22 2002-08-08 Waldon R. Forrest Methods and formulations for the treatment of female sexual dysfunction
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
US20050287203A1 (en) * 2002-05-08 2005-12-29 Nijs De H Formulation comprising testosteron undecanoate and castor oil
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
EP1530965B1 (en) * 2003-11-11 2006-03-08 Mattern, Udo Controlled release delivery system of sexual hormones for nasal application
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
EP1853272A1 (en) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
PT2068825E (pt) 2006-10-04 2011-02-11 M & P Patent Ag Sistema de administração de libertação controlada para aplicação nasal de neurotransmissores
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
AR086400A1 (es) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
HUE055562T2 (hu) 2011-11-23 2021-11-29 Therapeuticsmd Inc Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990414A (en) * 1957-03-26 1961-06-27 Syntex Sa 17-undecenoate of estradiol
CH502326A (de) * 1966-12-09 1971-01-31 Ciba Geigy Ag Verfahren zur Herstellung von Aldehyden der Pregnanreihe und ihrer Derivate
US3484465A (en) * 1967-09-07 1969-12-16 Syntex Corp Bicyclo(2.2.2)octane - 1-carboxylate carbonate esters of estrogenic steroids
US3608075A (en) * 1969-07-28 1971-09-21 American Home Prod Compositions and methods of treating the menopausal syndrome
FR2248029B1 (pt) * 1973-10-19 1977-03-11 Roussel Uclaf
US3916002A (en) * 1973-12-17 1975-10-28 Taubert Hans Dieter Oligomeric steroid esters, process for their production, and therapeutic compositions containing the same
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Also Published As

Publication number Publication date
BE842329A (fr) 1976-11-29
AU1413576A (en) 1977-11-24
DE2661011C2 (de) 1986-12-11
GB1553731A (en) 1979-09-26
US4071623A (en) 1978-01-31
PH13841A (en) 1980-10-16
FR2312256B1 (pt) 1980-04-30
IL49640A (en) 1980-10-26
LU75039A1 (pt) 1977-01-20
HU176742B (en) 1981-05-28
GR58257B (en) 1977-09-15
NL7506407A (nl) 1976-12-02
DE2624025A1 (de) 1976-12-09
JPS51144736A (en) 1976-12-13
AU505898B2 (en) 1979-12-06
DE2624025C2 (pt) 1989-03-16
NZ180980A (en) 1978-06-20
IE42692L (en) 1976-11-30
FR2312256A1 (fr) 1976-12-24
JPS62281892A (ja) 1987-12-07
GB1553732A (en) 1979-09-26
IL49640A0 (en) 1976-12-31
IE42692B1 (en) 1980-09-24
JPS6245845B2 (pt) 1987-09-29

Similar Documents

Publication Publication Date Title
ZA762920B (en) Novel pharmaceutical preparation adapted for oral administration
ZA764868B (en) Novel pharmaceutical preparation adapted for oral administration
PH12959A (en) Preparation of pharmaceutical unit dosage form
ZA741963B (en) Oral drug preparations
ZA7671B (en) Pharmaceutical composition
GB1539076A (en) Process for preparing preparations for oral administration
JPS5272829A (en) Pharmaceutical composition
NZ180321A (en) Sustained release pharmaceutical preparation
ZA751007B (en) Oral pharmaceutical preparation
IL51096A0 (en) Novel pharmaceutical dosage form
IL48806A0 (en) New biphenyloxy derivatives,their preparation and pharmaceutical compositions containing them
AU504182B2 (en) Pharmaceutical dosage forms
KE3219A (en) Pharmaceutical compositions
GB1549171A (en) Pharmaceutical formulations containing hydrocy bezophenonederivatives
IL49758A0 (en) Novel phenothiazine derivatives,their preparation and pharmaceutical compositions containing them
IL50816A0 (en) Novel 6-aryl-s-triazolo(4,3a)pyrido(2,3-f)(1,4-diazepines),their preparation and pharmaceutical compositions containing them
AU1306576A (en) Pharmaceutical formulation
IL48791A0 (en) Novel penicillin derivatives,their preparation and pharmaceutical compositions containing them
GB1550359A (en) Antibiotic compositions for oral administration
HU173823B (hu) Sposob poluchenija stabil'nogo lechebnogo preparata dlja oral'noj dozirovki, kotoryj soderzhit proizvodnyj gomopirimidazola
PH13439A (en) Method of preparing solid pharmaceutical unit dosage form
GB1552416A (en) Pharmaceutical compositions
ZA767215B (en) Pharmaceutical compositions
GB1539031A (en) Pharmaceutical compositions
GB1367608A (en) Oral pharmaceutical dosage form